Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Cache domain containing protein | 0.1778 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.2074 | 0.042 | 0.0693 |
Schistosoma mansoni | serine-rich repeat protein | 0.2074 | 0.042 | 0.0693 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.883 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1778 | 0 | 0.5 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.3852 | 0.2941 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 7 % | Percent assembly of bovine brain tubulin induced by compound at 10 uM versus that caused by 10 uM paclitaxel | ChEMBL. | 12825928 |
Activity (functional) | = 7 % | Percent assembly of bovine brain tubulin induced by compound at 10 uM versus that caused by 10 uM paclitaxel | ChEMBL. | 12825928 |
Activity (functional) | = 10 % | Percent competition for binding to preformed microtubules by 4 uM of the compound as against 2 uM of 3[H]paclitaxel | ChEMBL. | 12825928 |
GI50 (functional) | > 50 nM | Inhibitory concentration of the compound against MBA-MB231 (breast) cells | ChEMBL. | 12825928 |
GI50 (functional) | > 50 nM | Inhibitory concentration of the compound against PC3 (prostrate) cells | ChEMBL. | 12825928 |
GI50 (functional) | > 50 nM | Inhibitory concentration of the compound against 2008 (ovarian) cells | ChEMBL. | 12825928 |
GI50 (functional) | > 50 nM | Inhibitory concentration of the compound against PC3 (prostrate) cells | ChEMBL. | 12825928 |
GI50 (functional) | > 50 nM | Inhibitory concentration of the compound against 2008 (ovarian) cells | ChEMBL. | 12825928 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.